Evidence map›Paper›PMID 38538288›Full record

ArticleFrontiers in bioscience (Landmark edition)2024

Chronic Viral Infection Compromises the Quality of Circulating Mucosal-Associated Invariant T Cells and Follicular T Helper Cells via Expression of Inhibitory Receptors.

Jaisheela Vimali, Yean K Yong, Amudhan Murugesan, Hong Y Tan, Ying Zhang, Rajeev Ashwin, Sivadoss Raju, Pachamuthu Balakrishnan, Marie Larsson, Vijayakumar Velu and 1 more

Open access · goldAbstract read
PubMed Publisher
In one paragraph

Article in Frontiers in bioscience (Landmark edition), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Jaisheela VimaliInfection and Inflammation, Department of Biotechnology, Central University of Tamil Nadu, 610005 Thiruvarur, India.
Yean K YongLaboratory Centre, Xiamen University Malaysia, 43900 Sepang, Selangor, Malaysia.
Amudhan MurugesanDepartment of Microbiology, Government Theni Medical College and Hospital, 625512 Theni, India.
Hong Y TanSchool of Traditional Chinese Medicine, Xiamen University Malaysia, 43900 Sepang, Selangor, Malaysia.
Ying ZhangChemical Engineering, Xiamen University Malaysia, 43900 Sepang, Selangor, Malaysia.
Rajeev AshwinInfection and Inflammation, Department of Biotechnology, Central University of Tamil Nadu, 610005 Thiruvarur, India.
Sivadoss RajuState Public Health Laboratory, Directorate of Public Health and Preventive Medicine, DMS Campus, 600018 Teynampet, Chennai, India.
Pachamuthu BalakrishnanCenter for Infectious Diseases, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, 602105 Chennai, Tamil Nadu, India.
Marie LarssonDivision of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, 58185 Linköping, Sweden.
Vijayakumar VeluDepartment of Pathology and Laboratory Medicine, Emory National Primate Research Center, Emory University, Atlanta, GA 30322, USA.
Esaki M ShankarInfection and Inflammation, Department of Biotechnology, Central University of Tamil Nadu, 610005 Thiruvarur, India.
Central University of Tamil Nadu · INXiamen University Malaysia · MYEmory University · USLinköping University · SESaveetha University · IN

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
NIAID NIH HHS P30 AI050409ODCDC CDC HHS P51 OD011132
6 · The paper itself

Abstract

backgroundChronic viral infection results in impaired immune responses rendering viral persistence. Here, we compared the quality of T-cell responses among chronic hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV)-infected individuals by examining the levels of expression of selected immune activation and exhaustion molecules on circulating MAIT cells and Tfh cells.

methodsCytokines were measured using a commercial Bio-plex Pro Human Cytokine Grp I Panel 17-plex kit (BioRad, Hercules, CA, USA). Inflammation was assessed by measuring an array of plasma cytokines, and phenotypic alterations in CD4+ T cells including circulating Tfh cells, CD8+ T cells, and TCR iVα7.2+ MAIT cells in chronic HBV, HCV, and HIV-infected patients and healthy controls. The cells were characterized based on markers pertaining to immune activation (CD69, ICOS, and CD27) proliferation (Ki67), cytokine production (TNF-α, IFN-γ) and exhaustion (PD-1). The cytokine levels and T cell phenotypes together with cell markers were correlated with surrogate markers of disease progression.

resultsThe activation marker CD69 was significantly increased in CD4+hi T cells, while CD8+ MAIT cells producing IFN-γ were significantly increased in chronic HBV, HCV and HIV infections. Six cell phenotypes, viz., TNF-α+CD4+lo T cells, CD69+CD8+ T cells, CD69+CD4+ MAIT cells, PD-1+CD4+hi T cells, PD-1+CD8+ T cells, and Ki67+CD4+ MAIT cells, were independently associated with decelerating the plasma viral load (PVL). TNF-α levels showed a positive correlation with increase in cytokine levels and decrease in PVL.

conclusionChronic viral infection negatively impacts the quality of peripheral MAIT cells and Tfh cells via differential expression of both activating and inhibitory receptors.

Indexed as

Hepatitis B, ChronicHepatitis CHIV InfectionsMucosal-Associated Invariant T CellsCytokinesHepatitis B virusHIVHumansKi-67 AntigenProgrammed Cell Death 1 ReceptorT-Lymphocytes, Helper-InducerTumor Necrosis Factor-alphaCytokinesKi-67 AntigenProgrammed Cell Death 1 ReceptorTumor Necrosis Factor-alphaHBVHIVMAIT cellsPD-1T cell exhaustion

Identifiers

PMID38538288
OpenAlexW4393092422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.